News
Douglas Altshuler, a former SpaceX employee with Crohn's disease, is suing the company for disability discrimination and ...
A former SpaceX employee, Douglas Altshuler, is suing the company, alleging he was wrongfully terminated due to his Crohn's ...
Douglas Altshuler, a former SpaceX employee, has filed a lawsuit alleging wrongful termination and disability discrimination. He claims he was fired after being reprimanded for frequent bathroom use ...
Douglas Altshuler recently filed a federal complaint in California, alleging that Musk's firm discriminated against him due ...
Douglas Altshuler, 58, recently filed a federal lawsuit in California claiming he was discriminated against by Musk's company because of his Crohn’s disease.
The primary endpoint of comprehensive disease control was defined as a combination of clinical remission (CDAI under 150; ...
Exclusive: If 58-year-old Douglas Altshuler spent more than 10 minutes on the toilet, he received a formal reprimand, the ...
Number 5: The authors of a review article on the future of ustekinumab biosimilars for treating Crohn disease (CD) discussed key challenges, including a lack of data in CD and opportunities to improve ...
Over thanksgiving, Bishop England girls soccer player Shae Kelly started to feel ill. Initially brushing it off, the symptoms grew to be more and more painful.
A new study finds that women with rheumatoid arthritis, lupus, or other autoimmune conditions have twice the risk of dying ...
Research and Development (R&D) expenses: R&D expenses were $22.9 million for the first quarter of 2025, compared to $33.7 million for the first quarter of 2024. General and Administrative (G&A) ...
The FDA approved ustekinumab-aekn (Selarsdi) injection as an interchangeable biosimilar to Stelara for the treatment of Crohn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results